Who are we?

Mabion is BioTech Company founded by four pharmaceutical companies:

Celon Pharma Ltd.,
Polfarmex Co.,
Genexo Ltd.,
IBSS Biomed Co.

and companies focused on research and development in biotechnology field:

BioCentrum Ltd.,
Biotech Consulting Ltd.

Company started operations in march 2007. Mabion is focused on development of humanized monoclonal antibodies (mAbs) technology, the newest generation of biotechnological drugs.

Mabion has developed proprietary technology of manufacturing of humanized monoclonal antibodies. Company has already started development of first two oncology drugs. The first product will be used in breast cancer, the second in lymphoma therapy.

Experience acquired during development of first medicines will help us to develop next products which can be applied in therapy of other cancers and immunological diseases.